Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR Mina NakagawaYasuhiro AsahinaRyuichi Okamoto Review 30 December 2022 Pages: 299 - 310
Correction: Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR Mina NakagawaYasuhiro AsahinaRyuichi Okamoto Correction 09 February 2023 Pages: 311 - 312
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021 Hiroshi NakaseMotohiro Esakithe TRADE consensus group Review Open access 11 February 2023 Pages: 313 - 345
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan Waku HattaYosuke Toyafor Tohoku GI Endoscopy Group Original Article—alimentary Tract 12 January 2023 Pages: 346 - 357
Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the management of gastric ESD: a multicenter noninferiority randomized study Motohiko KatoNaoki HosoeTakanori Kanai Original Article—Alimentary Tract 13 February 2023 Pages: 358 - 366
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia Mariko KobayashiShintaro AkiyamaNaoyoshi Nagata Original Article—alimentary Tract 23 December 2022 Pages: 367 - 378
Organoids transplantation as a new modality to design epithelial signature to create a membrane-protective sulfomucin-enriched segment Satoshi WatanabeNobuhiko OgasawaraShiro Yui Original Article—Alimentary Tract 06 February 2023 Pages: 379 - 393
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis Kohei KotaniMasaru EnomotoNorifumi Kawada Original Article―Liver, Pancreas, and Biliary Tract Open access 02 February 2023 Pages: 394 - 404
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study Tatsuki MizuochiItaru IwamaHitoshi Tajiri Original Article―Liver, Pancreas, and Biliary Tract 15 February 2023 Pages: 405 - 412
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis Yizhen FuWei PengYaojun Zhang Original Article―Liver, Pancreas, and Biliary Tract 09 March 2023 Pages: 413 - 424
The role of sex hormones in the fecal microbiota of IBS-D patients with exacerbation of symptoms deserves attention Jieyi WangLinhui TaoMingxian Chen Letter to the Editor 31 December 2022 Pages: 425 - 426
Further notice of omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation Yukari TanakaRiu YamashitaShin Fukudo Letter to the Editor 07 February 2023 Pages: 427 - 428
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development Munemasa NagaoAkihisa Fukuda Editorial 11 March 2023 Pages: 429 - 430
Correction to: Expert consensus on vaccination in patients with inflammatory bowel disease in Japan Takashi IshigeToshiaki ShimizuTadakazu Hisamatsu Correction Open access 10 February 2023 Pages: 431 - 432